Cas no 1867-73-8 (N6-Methyladenosine)
N6-Methyladenosine Chemical and Physical Properties
Names and Identifiers
-
- Adenosine, N-methyl-
- N6-Methyladenosine
- (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol
- 6-Methylaminopurine ribonucleoside
- 6-methylaminoqurine 9-ribofuranoside
- 6-Methyladenosine
- 6-METHYLAMINOPURINE 9-RIBOFURANOSIDE
- 6-Methylaminopurine D-riboside
- 6-methylaminopurine riboside
- 6-Methylaminopurinosine
- 6-N-Methyladenoside
- Adenosine,N-methyl
- N(6)-methyladenosine
- N-Methyladenosine
- 6-Methylamino-9-b-D-ribofuranosylpurine
- 9-b-D-Ribofuranosyl-N6-methylaminopurine
- NSC 29409
- N6-Me-A
- N6-Me-rA
- NSC-29409
- N6-methyladenosine (m6A)
- 6-Methylaminopurineriboside
- (N-6)-Methyladenosine
- N(6)-monomethyladenosine
- CLE6G00625
- M6A
- (2R,3S,4R,5R)-2-Hydroxymethyl-5-(6-m
- Prestwick2_000338
- MFCD00005739
- Purine, 6-methylamino-9-beta-D-ribofuranosyl-
- Epitope ID:140951
- N6 -methyladenosine
- (2R,3S,4R,5R)-2-Hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetrahydro-furan-3,4-diol
- Prestwick3_000338
- (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)-9H-purin-9-yl]oxolane-3,4-diol
- NSC627045
- HMS3713C17
- BDBM50163023
- Prestwick1_000338
- BPBio1_000413
- F12902
- DTXSID6020858
- MLS002153780
- 4rdn
- SPBio_002296
- AKOS024260287
- CHEBI:21891
- SCHEMBL40634
- s3190
- VQAYFKKCNSOZKM-IOSLPCCCSA-N
- SW196617-3
- BRD-K81807412-001-03-1
- PDSP1_001030
- CCG-220338
- NCGC00162241-09
- Q6951996
- EN300-255003
- 6MD
- NCGC00162241-02
- NCGC00162241-01
- HY-N0086
- UNII-CLE6G00625
- SMR001233164
- Z2088406258
- NCGC00162241-04
- 1867-73-8
- HMS2234N05
- Prestwick0_000338
- HMS1569C17
- PDSP2_001014
- (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]tetrahydrofuran-3,4-diol
- 6-methylamino-9-beta-D-ribofuranosyl-Purine
- (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolane-3,4-diol
- J-700317
- BSPBio_000375
- CHEMBL383144
- BP-58658
- 6-Methyladenosine;N-Methyladenosine
- GS-6701
- CS-3285
- 6-methylamino-9-beta-delta-ribofuranosyl-Purine
- HMS2096C17
- Prestwick_343
- DA-65904
- adenosine, N(6)-methyl-
- 1ST167094-1000AW
- GLXC-20834
- N6-Methyladenosine Solution in Acetonitrile/Water, 1000ug/mL
- BRD-K81807412-001-10-6
-
- MDL: MFCD00005739
- Inchi: 1S/C11H15N5O4/c1-12-9-6-10(14-3-13-9)16(4-15-6)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11,17-19H,2H2,1H3,(H,12,13,14)/t5-,7-,8-,11-/m1/s1
- InChI Key: VQAYFKKCNSOZKM-IOSLPCCCSA-N
- SMILES: O1[C@H](CO)[C@H]([C@H]([C@@H]1N1C=NC2C(NC)=NC=NC1=2)O)O
Computed Properties
- Exact Mass: 281.11200
- Monoisotopic Mass: 281.112
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 20
- Rotatable Bond Count: 3
- Complexity: 349
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.4
- Topological Polar Surface Area: 126
Experimental Properties
- Density: 1.85
- Boiling Point: 649.1°C at 760 mmHg
- Flash Point: 346.3°C
- Refractive Index: 1.814
- PSA: 125.55000
- LogP: -1.44750
N6-Methyladenosine Security Information
- Hazard Statement: H302-H315-H319-H335
- Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
N6-Methyladenosine Customs Data
- HS CODE:2934999090
- Customs Data:
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
N6-Methyladenosine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-N0086-10mM*1mLinDMSO |
N6-Methyladenosine |
1867-73-8 | 98.96% | 10mM*1mLinDMSO |
¥550 | 2022-05-18 | |
| MedChemExpress | HY-N0086-100mg |
N6-Methyladenosine |
1867-73-8 | 98.96% | 100mg |
¥800 | 2024-04-19 | |
| MedChemExpress | HY-N0086-500mg |
N6-Methyladenosine |
1867-73-8 | 98.96% | 500mg |
¥1500 | 2022-03-28 | |
| SHANG HAI XIANG HUI YI YAO Technology Co., Ltd. | CB31297-0.1g |
N6-Methyladenosine |
1867-73-8 | 97% | 0.1g |
352.00 | 2021-06-01 | |
| SHANG HAI XIANG HUI YI YAO Technology Co., Ltd. | CB31297-0.25g |
N6-Methyladenosine |
1867-73-8 | 97% | 0.25g |
588.00 | 2021-06-01 | |
| SHANG HAI XIANG HUI YI YAO Technology Co., Ltd. | CB31297-1g |
N6-Methyladenosine |
1867-73-8 | 97% | 1g |
1225.00 | 2021-06-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | N191760-250mg |
N6-Methyladenosine |
1867-73-8 | 98% | 250mg |
¥129.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | N191760-1g |
N6-Methyladenosine |
1867-73-8 | 98% | 1g |
¥339.90 | 2023-09-01 | |
| S e l l e c k ZHONG GUO | S3190-50mg |
N6-methyladenosine (m6A) |
1867-73-8 | 99.79% | 50mg |
¥731.62 | 2023-09-19 | |
| ChemScence | CS-3285-100mg |
N6-Methyladenosine |
1867-73-8 | 99.07% | 100mg |
$33.0 | 2022-04-27 |
N6-Methyladenosine Suppliers
N6-Methyladenosine Related Literature
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
-
Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
Related Categories
- Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides Purine nucleosides
- Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Purine nucleosides
- Solvents and Organic Chemicals Organic Compounds Acids/Esters
- Other Chemical Reagents
Additional information on N6-Methyladenosine
Introduction to N6-Methyladenosine (CAS No. 1867-73-8)
N6-Methyladenosine (N6-mA) is a significant nucleotide modification that has garnered considerable attention in the field of molecular biology and pharmacology. This modified adenosine derivative, identified by its chemical abstracts service number CAS No. 1867-73-8, plays a crucial role in various biological processes, including RNA metabolism and regulation. The structural modification at the N6 position of adenosine imparts unique biochemical properties, making N6-mA a subject of extensive research in both academic and industrial settings.
The significance of N6-mA lies in its widespread presence across different organisms, suggesting its fundamental importance in cellular functions. Recent studies have highlighted the involvement of N6-mA in the maturation and stability of various non-coding RNAs, which are essential for gene expression regulation. This discovery has opened new avenues for understanding the complex interplay between RNA modifications and cellular pathways.
One of the most intriguing aspects of N6-mA is its role in modulating RNA splicing. RNA splicing is a critical process that ensures the correct assembly of mRNA from pre-mRNA transcripts. Research has demonstrated that N6-mA can influence the efficiency and accuracy of splicing events, thereby affecting the production of functional proteins. This has profound implications for diseases associated with aberrant splicing, such as certain genetic disorders and cancers.
Furthermore, N6-mA has been implicated in the regulation of mRNA stability and translation efficiency. Post-transcriptional modifications like N6-mA can alter the half-life of mRNA molecules, thereby controlling the levels of specific proteins within the cell. This regulatory mechanism is particularly important in dynamic cellular environments where rapid adjustments in protein synthesis are required.
The pharmacological potential of N6-mA has also been explored extensively. Several studies have indicated that synthetic analogs of N6-mA can modulate various biological pathways, offering therapeutic benefits in conditions such as neurodegenerative diseases and inflammation. The ability to precisely target RNA modifications opens up new possibilities for developing novel drug candidates with improved efficacy and reduced side effects.
Advances in high-throughput sequencing technologies have enabled researchers to delve deeper into the landscape of RNA modifications, including N6-mA. These technologies have revealed that N6-mA is not randomly distributed across RNAs but is often localized to specific regions, suggesting functional significance. This spatial organization may be critical for understanding how N6-mA influences RNA function at a systems level.
In conclusion, N6-Methyladenosine (CAS No. 1867-73-8) is a pivotal nucleotide modification with far-reaching implications in biology and medicine. Its involvement in RNA maturation, splicing regulation, mRNA stability, and translation efficiency underscores its importance in cellular processes. The growing body of research on N6-mA not only enhances our understanding of fundamental biological mechanisms but also paves the way for innovative therapeutic strategies targeting RNA modifications.
1867-73-8 (N6-Methyladenosine) Related Products
- 60209-41-8(9H-Purin-6-amine, 9-b-D-arabinofuranosyl-N-methyl-)
- 98897-14-4(N6-(Hydroxymethyl)adenosine (~90%))
- 65494-95-3(9H-Purin-6-amine,N-methyl-9-b-D-xylofuranosyl-)
- 111863-61-7(Adenosine,N,N''-1,6-hexanediylbis- (9CI))
- 111863-65-1(Adenosine,N,N''-1,12-dodecanediylbis- (9CI))
- 7770-17-4(9H-Purin-6-amine, 9-b-D-arabinofuranosyl-N,N-dimethyl-)
- 57821-29-1(heparin-like substance: sulodexide*sodium from bo)
- 111863-62-8(Adenosine,N,N''-1,8-octanediylbis- (9CI))
- 14357-08-5(N6-Ethyladenosine)
- 2620-62-4(N6,N6-Dimethyladenosine)